Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-04-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluorescence Cholangiography During Cholecystectomy - a RCT
NCT02344654
Fluorescent Cholangiography and Bile Duct Stones
NCT03530241
Magnetic Resonance Cholangiography and Intraoperative Cholangiography in Acute Cholecystitis
NCT04059601
Promising Initial Experience With Intra-operative Fluorescent Cholangiography
NCT02136095
Fluorescent Cholangiography in Acute Cholecystitis
NCT06573021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluorescent cholangiography
Intraoperative fluorescent cholangiography using an intravenous injection of 5mg Indocyanine green
Cholangiography
All patients will be subjected to intraoperative fluorescent and concommitant X-ray cholangiography
X-ray cholangiography
Intraoperative X-ray cholangiography using an intraductal (cystic duct) injection of Iohexol
Cholangiography
All patients will be subjected to intraoperative fluorescent and concommitant X-ray cholangiography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cholangiography
All patients will be subjected to intraoperative fluorescent and concommitant X-ray cholangiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Allergy towards iodine, Iohexol or indocyanine green
* Legally incompetent (any reason)
* Cholangitis (as defined above)15
* Withdrawal of inclusion consent at any time
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillerod Hospital, Denmark
OTHER
Zealand University Hospital
OTHER
Hvidovre University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Lang Lehrskov
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northzealand Hospiral Hillerød
Hillerød, Danmark, Denmark
Hvidovre University Hospital
Hvidovre, Danmark, Denmark
Zealand University Hospital Køge
Køge, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IFC3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.